Enzo Bonora Selected Research

Hemoglobin A

3/2012	Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.
1/2012	Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus.
10/2010	Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enzo Bonora Research Topics

Disease

52	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2002
29	Insulin Resistance 01/2022 - 07/2002
15	Hypertension (High Blood Pressure) 01/2020 - 07/2002
10	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 07/2002
9	Albuminuria 05/2021 - 09/2009
9	Chronic Renal Insufficiency 01/2020 - 05/2011
8	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022 - 10/2009
8	Body Weight (Weight, Body) 01/2022 - 08/2017
8	Non-alcoholic Fatty Liver Disease 10/2018 - 10/2010
7	Obesity 01/2022 - 07/2004
5	Weight Loss (Weight Reduction) 01/2022 - 10/2015
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2017 - 04/2003
5	Inflammation (Inflammations) 01/2017 - 01/2006
5	Dyslipidemias (Dyslipidemia) 12/2016 - 07/2004
4	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 02/2002
4	Hypoglycemia (Reactive Hypoglycemia) 06/2019 - 04/2016
4	Diabetes Mellitus 01/2019 - 08/2013
4	Myocardial Ischemia (Ischemic Heart Diseases) 12/2017 - 12/2016
3	Myocardial Infarction 01/2019 - 08/2012
3	Hypercholesterolemia 05/2017 - 01/2014
3	Overweight 01/2016 - 07/2004
3	Atherosclerosis 06/2015 - 07/2002
2	Hyperandrogenism 01/2022 - 02/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 11/2016
2	Abdominal Obesity 12/2019 - 04/2008
2	Hyperglycemia 01/2019 - 07/2004
2	Hypothyroidism 10/2018 - 10/2009
2	Diabetic Foot 01/2018 - 01/2018
2	Ulcer 01/2018 - 01/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2017 - 09/2013
2	Atrial Fibrillation 12/2017 - 01/2017
2	Heart Block 12/2017 - 01/2017
2	Heart Valve Diseases (Valvular Heart Disease) 12/2017 - 09/2013
2	Atherosclerotic Plaque (Atheroma) 05/2017 - 06/2016
2	Heart Failure 04/2016 - 09/2013
2	Donohue Syndrome 12/2013 - 03/2008
2	Renal Insufficiency (Renal Failure) 08/2013 - 08/2013
2	Hyperuricemia 01/2012 - 11/2008
2	Glucose Intolerance 07/2004 - 07/2002
1	Morbid Obesity 01/2022
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2022
1	Vomiting 10/2021
1	Diarrhea 10/2021
1	Nausea 10/2021
1	Weight Gain 10/2021
1	Insulinoma 01/2019
1	Acute Coronary Syndrome 01/2019
1	Margins of Excision 01/2019

Drug/Important Bio-Agent (IBA)

31	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2002
20	Insulin (Novolin)FDA Link 01/2022 - 02/2002
12	Hemoglobins (Hemoglobin)IBA 01/2020 - 06/2010
11	HDL CholesterolIBA 01/2021 - 01/2006
11	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2006
11	LipidsIBA 10/2020 - 07/2002
7	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 04/2011
7	AndrogensIBA 01/2022 - 05/2012
7	CholesterolIBA 01/2021 - 07/2002
7	CreatinineIBA 10/2020 - 09/2011
6	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 08/2013
6	LDL CholesterolIBA 01/2021 - 02/2007
6	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 09/2009
5	dulaglutideIBA 12/2021 - 01/2021
5	Antihypertensive Agents (Antihypertensives)IBA 08/2012 - 09/2009
4	Testosterone (Sustanon)FDA Link 01/2022 - 05/2012
4	C-PeptideIBA 01/2020 - 03/2008
4	Uric Acid (Urate)IBA 12/2017 - 11/2008
3	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2006
3	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2019 - 04/2016
3	Pioglitazone (Actos)FDA Link 01/2019 - 12/2012
3	C-Reactive ProteinIBA 11/2018 - 02/2007
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2017 - 02/2007
3	oxidized low density lipoproteinIBA 01/2014 - 01/2006
3	Hemoglobin AIBA 03/2012 - 10/2010
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2018
2	Liraglutide FDA Link 01/2022 - 11/2016
2	Exenatide (Byetta)FDA Link 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2016
2	Biological ProductsIBA 01/2018 - 01/2013
2	empagliflozinIBA 08/2017 - 11/2016
2	Vitamin D FDA LinkGeneric 01/2015 - 01/2013
2	Hemostatics (Antihemorrhagics)IBA 07/2014 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 03/2014 - 03/2008
2	Fibrinogen (Factor I)FDA Link 01/2014 - 02/2007
2	PotassiumIBA 12/2013 - 03/2008
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2012 - 09/2009
2	Oxidants (Oxidizing Agents)IBA 01/2008 - 02/2002
1	Hormones (Hormone)IBA 01/2022
1	semaglutideIBA 01/2022
1	HDL-triglycerideIBA 01/2021
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 11/2020
1	SubtilisinIBA 11/2020
1	Zinc Transporter 8IBA 11/2019
1	Edotreotide (SMT 487)IBA 01/2019

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2012
4	Glycemic Control 01/2022 - 10/2015
3	Bariatric Surgery 01/2021 - 10/2015
3	Resistance Training 01/2019 - 04/2012
2	Blood Component Removal (Apheresis) 11/2018 - 01/2014
1	Pancreatectomy 01/2019